Free Trial
NASDAQ:VIRI

Virios Therapeutics (VIRI) Stock Price, News & Analysis

$0.24
+0.01 (+4.38%)
(As of 06/14/2024 ET)
Today's Range
$0.22
$0.26
50-Day Range
$0.18
$0.51
52-Week Range
$0.16
$2.42
Volume
972,327 shs
Average Volume
717,741 shs
Market Capitalization
$4.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Virios Therapeutics MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.74% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.43mentions of Virios Therapeutics in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.27) to ($0.19) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.32 out of 5 stars

VIRI stock logo

About Virios Therapeutics Stock (NASDAQ:VIRI)

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

VIRI Stock Price History

VIRI Stock News Headlines

Virios Therapeutics, Inc. (VIRI)
See More Headlines
Receive VIRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
6/14/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VIRI
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-5,300,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.20 per share

Miscellaneous

Free Float
16,909,000
Market Cap
$4.59 million
Optionable
Optionable
Beta
1.62
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Mr. Gregory Duncan (Age 59)
    Chairman & CEO
    Comp: $566.92k
  • Dr. William L. Pridgen M.D. (Age 63)
    Founder & Director
    Comp: $35k
  • Ms. Angela Walsh (Age 57)
    CFO, SVP of Finance, Corporate Secretary & Treasurer
    Comp: $282.64k
  • Dr. R. Michael Gendreau M.D. (Age 68)
    Ph.D., Chief Medical Officer
    Comp: $364.94k
  • Mr. Ralph D. Grosswald M.P.H. (Age 55)
    Senior Vice President of Operations
    Comp: $274.69k
  • Ms. Carol Duffy Ph.D.
    Chief Scientific Advisor

VIRI Stock Analysis - Frequently Asked Questions

How have VIRI shares performed in 2024?

Virios Therapeutics' stock was trading at $0.5750 at the start of the year. Since then, VIRI shares have decreased by 58.6% and is now trading at $0.2382.
View the best growth stocks for 2024 here
.

Are investors shorting Virios Therapeutics?

Virios Therapeutics saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 335,300 shares, an increase of 233.6% from the May 15th total of 100,500 shares. Based on an average trading volume of 1,020,000 shares, the short-interest ratio is currently 0.3 days.
View Virios Therapeutics' Short Interest
.

When is Virios Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024.
View our VIRI earnings forecast
.

How were Virios Therapeutics' earnings last quarter?

Virios Therapeutics, Inc. (NASDAQ:VIRI) issued its quarterly earnings results on Thursday, May, 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.01.

When did Virios Therapeutics IPO?

Virios Therapeutics (VIRI) raised $30 million in an initial public offering on Thursday, December 17th 2020. The company issued 3,000,000 shares at a price of $9.00-$11.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

How do I buy shares of Virios Therapeutics?

Shares of VIRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VIRI) was last updated on 6/14/2024 by MarketBeat.com Staff

From Our Partners